NCT01427153

Brief Summary

The purpose of this study is to compare an orthopaedic manual physical therapy (OMPT) approach to a corticosteroid injection approach for the management of knee osteoarthritis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
156

participants targeted

Target at P75+ for not_applicable knee-osteoarthritis

Timeline
Completed

Started Aug 2012

Longer than P75 for not_applicable knee-osteoarthritis

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 30, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 1, 2011

Completed
11 months until next milestone

Study Start

First participant enrolled

August 1, 2012

Completed
5.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2018

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2019

Completed
Last Updated

January 27, 2025

Status Verified

July 1, 2020

Enrollment Period

5.8 years

First QC Date

August 30, 2011

Last Update Submit

January 23, 2025

Conditions

Keywords

knee osteoarthritisphysical therapycorticosteroidtreatment

Outcome Measures

Primary Outcomes (1)

  • Western Ontario McMasters Osteoarthritis Index (WOMAC)

    The WOMAC is a self report questionnaire that asks patient to rate their pain, stiffness, and functional limitation associated with their condition. This instrument will provide important information about the self-reported pain and disability level of the patients in this study. The WOMAC is a recommended primary outcome measure in therapy trials of arthritic conditions, and is considered one of the most appropriate scales for trials evaluating knee osteoarthritis (OA). It is a reliable, valid, and responsive instrument widely used in clinical trials evaluating therapy for hip and knee OA

    1 year

Secondary Outcomes (3)

  • Global Rating of Change (GROC)

    1 Year

  • Alternate Step Test (AST)

    1 Year

  • Timed Up and Go Test (TUG)

    1 Year

Study Arms (2)

Corticosteroid

ACTIVE COMPARATOR

Corticosteroid injection

Procedure: Corticosteroid Injection

Orthopaedic Manual Physical Therapy

ACTIVE COMPARATOR

OMPT consists of joint and soft-tissue mobilizations and the exercises that reinforce the manual techniques.

Procedure: Orthopaedic manual physical therapy

Interventions

OMPT consists of joint and soft-tissue mobilizations and the exercises that reinforce the manual techniques.

Orthopaedic Manual Physical Therapy

Corticosteroid injection to the tibiofemoral joint

Corticosteroid

Eligibility Criteria

Age38 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All subjects must be eligible for care in the military health system
  • Meet Altman's clinical criteria for knee OA
  • Have English language skills sufficient to complete the WOMAC and GROC outcome instruments
  • Be 38 years of age or older

You may not qualify if:

  • Steroid injections or physical therapy treatment for their knee in the past 12 months
  • Current or past history of rheumatoid arthritis or similar rheumatic condition
  • Current or past history of gout or pseudogout of the knee
  • Active infection in the knee within the past 12 months
  • Other physical ailment or condition that is typically more limiting or painful than their knee OA during activities such as sitting, standing, walking, or stair climbing
  • History of allergy or adverse effect to corticosteroids
  • Cannot speak/read English adequately to understand and provide consent to participate in the study
  • Pregnant or intending to become pregnant
  • Military service members pending a medical evaluation board, physical evaluation board, equivalent discharge process, or on medical hold to determine long-term disposition. For non-military personnel, anyone that is pending or undergoing any litigation for this condition.
  • Contraindication to receiving a corticosteroid injection (history of allergic or adverse reaction to steroid injection, history of multiple corticosteroid injections in that area even if not within last year, etc)
  • Unable to give informed consent to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Brooke Army Medical Center

San Antonio, Texas, 78234, United States

Location

Madigan Army Medical Center

Tacoma, Washington, 98431, United States

Location

Related Publications (7)

  • Deyle GD, Allison SC, Matekel RL, Ryder MG, Stang JM, Gohdes DD, Hutton JP, Henderson NE, Garber MB. Physical therapy treatment effectiveness for osteoarthritis of the knee: a randomized comparison of supervised clinical exercise and manual therapy procedures versus a home exercise program. Phys Ther. 2005 Dec;85(12):1301-17.

    PMID: 16305269BACKGROUND
  • Deyle GD, Henderson NE, Matekel RL, Ryder MG, Garber MB, Allison SC. Effectiveness of manual physical therapy and exercise in osteoarthritis of the knee. A randomized, controlled trial. Ann Intern Med. 2000 Feb 1;132(3):173-81. doi: 10.7326/0003-4819-132-3-200002010-00002.

    PMID: 10651597BACKGROUND
  • Hepper CT, Halvorson JJ, Duncan ST, Gregory AJ, Dunn WR, Spindler KP. The efficacy and duration of intra-articular corticosteroid injection for knee osteoarthritis: a systematic review of level I studies. J Am Acad Orthop Surg. 2009 Oct;17(10):638-46. doi: 10.5435/00124635-200910000-00006.

    PMID: 19794221BACKGROUND
  • Godwin M, Dawes M. Intra-articular steroid injections for painful knees. Systematic review with meta-analysis. Can Fam Physician. 2004 Feb;50:241-8.

    PMID: 15000335BACKGROUND
  • Rhon DI, Kim M, Asche CV, Allison SC, Allen CS, Deyle GD. Cost-effectiveness of Physical Therapy vs Intra-articular Glucocorticoid Injection for Knee Osteoarthritis: A Secondary Analysis From a Randomized Clinical Trial. JAMA Netw Open. 2022 Jan 4;5(1):e2142709. doi: 10.1001/jamanetworkopen.2021.42709.

  • Deyle GD, Allen CS, Allison SC, Gill NW, Hando BR, Petersen EJ, Dusenberry DI, Rhon DI. Physical Therapy versus Glucocorticoid Injection for Osteoarthritis of the Knee. N Engl J Med. 2020 Apr 9;382(15):1420-1429. doi: 10.1056/NEJMoa1905877.

  • Deyle GD, Gill NW, Rhon DI, Allen CS, Allison SC, Hando BR, Petersen EJ, Dusenberry DI, Bellamy N. A multicenter randomised, 1-year comparative effectiveness, parallel-group trial protocol of a physical therapy approach compared to corticosteroid injection on pain and function related to knee osteoarthritis (PTA Trial). BMJ Open. 2016 Mar 31;6(3):e010528. doi: 10.1136/bmjopen-2015-010528.

MeSH Terms

Conditions

Osteoarthritis, Knee

Interventions

Adrenal Cortex Hormones

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

HormonesHormones, Hormone Substitutes, and Hormone Antagonists

Study Officials

  • Daniel Rhon, PT, DPT, DSc

    Madigan Army Medical Center

    PRINCIPAL INVESTIGATOR
  • Gail Deyle, PT, DPT, DSc

    Baylor University / Brooke Army Medical Center

    STUDY DIRECTOR
  • Steven Allison, PT, PhD

    Baylor University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Staff Physical Therapist

Study Record Dates

First Submitted

August 30, 2011

First Posted

September 1, 2011

Study Start

August 1, 2012

Primary Completion

May 1, 2018

Study Completion

May 1, 2019

Last Updated

January 27, 2025

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will share

Any data sharing must go through a Data Sharing Agreement approved by the US Defense Health Agency

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
These are all available in the supplementary appendix published in the trial results with NEJM
Access Criteria
All of this data is publicly available in open access publications and in the supplementary appendix of the version published on NEJM

Locations